Brazil vs Indonesia: HIV-positive TB patients on ART (antiretroviral therapy)
Brazil
59.0%
in 2024
Indonesia
54.0%
in 2024
Brazil rank
136th
Indonesia rank
138th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Brazil
- Indonesia
How they compare
Brazil currently reports 59.0% against 54.0% in Indonesia, a difference of 5.0%.
That makes Brazil's figure about 1.1 times Indonesia's.
Across all 14 years both countries report, Brazil has been ahead every year.
Brazil ranks 136th and Indonesia ranks 138th of 144 countries.
Brazil has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brazil | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 91.0% | 42.0% | 49.0% | Brazil |
| 2010s | 66.9% | 36.4% | 30.5% | Brazil |
| 2020s | 56.0% | 39.8% | 16.2% | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Brazil or Indonesia?
- Brazil, at 59.0% against 54.0% in Indonesia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Brazil and Indonesia?
- 5.0%, with Brazil ahead.
- How many years of comparable data are there for Brazil and Indonesia?
- 14 years are reported by both, from 2009 to 2024.
- How do Brazil and Indonesia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Brazil ranks 136th and Indonesia ranks 138th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.